(-)-Agelastatin B

ID: ALA3298663

Chembl Id: CHEMBL3298663

PubChem CID: 10454791

Max Phase: Preclinical

Molecular Formula: C12H12Br2N4O3

Molecular Weight: 420.06

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)N[C@H]2[C@@H]3NC(=O)c4cc(Br)c(Br)n4[C@@H]3C[C@]21O

Standard InChI:  InChI=1S/C12H12Br2N4O3/c1-17-11(20)16-8-7-6(3-12(8,17)21)18-5(10(19)15-7)2-4(13)9(18)14/h2,6-8,21H,3H2,1H3,(H,15,19)(H,16,20)/t6-,7-,8+,12+/m1/s1

Standard InChI Key:  IRISBJGHXIFQBW-GYAIJENASA-N

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.06Molecular Weight (Monoisotopic): 417.9276AlogP: 0.78#Rotatable Bonds:
Polar Surface Area: 86.60Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.12CX Basic pKa: CX LogP: 0.45CX LogD: 0.45
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.58Np Likeness Score: 1.98

References

1. Stout EP, Choi MY, Castro JE, Molinski TF..  (2014)  Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studies.,  57  (12): [PMID:24673739] [10.1021/jm4016922]
2. Jouanneau M, McClary B, Reyes JC, Chen R, Chen Y, Plunkett W, Cheng X, Milinichik AZ, Albone EF, Liu JO, Romo D..  (2016)  Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.,  26  (8): [PMID:26951751] [10.1016/j.bmcl.2016.02.051]

Source